Advances in Clinical Chemistry
- 1st Edition, Volume 105 - November 2, 2021
- Latest edition
- Editor: Gregory S. Makowski
- Language: English
Advances in Clinical Chemistry, Volume 105, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laborator… Read more
Advances in Clinical Chemistry, Volume 105, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on IgG N-glycans, Extracellular Vesicles: Potential Impact on Cardiovascular Diseases, Advances in Bone Turnover Markers, Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Kidney Disease, and The Prothrombotic State in Cancer.
- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world renowned clinical laboratory scientists, physicians and research scientists
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
Clinical Laboratory Professionals, Physicians and Research Scientists
1. IgG N-glycans
Si Liu and Xin Liu
2. Extracellular vesicles: Potential impact on cardiovascular diseases
Jian Yang, Xue Zou, Pedro A. Jose, and Chunyu Zeng
3. Advances in bone turnover markers
Lisa Di Medio and Maria Luisa Brandi
4. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease
Oskar Zakiyanov, Marta Kalousová, Tomáš Zima, and Vladimír Tesar
5. The prothrombotic state in cancer
Benjamín Rubio-Jurado, Lluvia Sugey Sosa-Quintero,Sandra Guzmán-Silahua, Eduardo García-Luna, Carlos Riebeling-Navarro, and Arnulfo Hernán Nava-Zavala
6. Urinary biohazard markers in firefighters
Bela Barros, Marta Oliveira, and Simone Morais
Si Liu and Xin Liu
2. Extracellular vesicles: Potential impact on cardiovascular diseases
Jian Yang, Xue Zou, Pedro A. Jose, and Chunyu Zeng
3. Advances in bone turnover markers
Lisa Di Medio and Maria Luisa Brandi
4. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease
Oskar Zakiyanov, Marta Kalousová, Tomáš Zima, and Vladimír Tesar
5. The prothrombotic state in cancer
Benjamín Rubio-Jurado, Lluvia Sugey Sosa-Quintero,Sandra Guzmán-Silahua, Eduardo García-Luna, Carlos Riebeling-Navarro, and Arnulfo Hernán Nava-Zavala
6. Urinary biohazard markers in firefighters
Bela Barros, Marta Oliveira, and Simone Morais
- Edition: 1
- Latest edition
- Volume: 105
- Published: November 2, 2021
- Language: English
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USARead Advances in Clinical Chemistry on ScienceDirect